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Abstract. It is well stated in the literature that medical treatment for peptic
ulcer is based on a combination of proton pump inhibitors (PPIs) and an-
tibiotics to eradicate Helicobacter pylori. This treatment is associated with a
high rate of immediate success and a low rate of recurrence at 12 months,
although it is not effective in all patients. Peptic ulcer (PU) perforation is a
serious problem that leads to high complication and mortality rates. Sur-
gical treatment, with its various possibilities, constitutes the ideal treat-
ment. Surgical intervention in these cases, however, can be directed to
treating the perforation alone, or it can offer definitive treatment of the
ulcer itself. With the hope of establishing why such complications and mor-
tality were seen in the patients in our hospital population, we gathered the
facts about PU perforations and the types of surgery performed. We studied
210 consecutive patients (150 men, 60 women) who had undergone surgery
at our hospital because of perforation between January 1, 1990 and Decem-
ber 31, 2000. The patients’ median age was 53.0 ± 20.6 years (men 47.7 ±
17.3 years; women 66.3 ± 22.0 years). Altogether, 86 patients had signifi-
cant associated illnesses, 62 were admitted more than 24 hours after the
perforation, and 25 were admitted in shock. We performed resections in 10
patients; 88 patients were treated by suturing the perforation with or with-
out a patch of epiploon; and 112 underwent a troncular vagotomy with
drainage (VT + Dr). A total of 21 patients died (10%). Significant risk
factors that led to complications were identified by statistical studies. They
were a perforation that had been present more than 24 hours, the coexist-
ence of significant associated illnesses, and resection surgery. The signifi-
cant risk factors that led to death were the presence of shock at admission,
the coexistence of significant illnesses, and resection surgery. There was no
statistically significant difference concerning morbidity and mortality be-
tween simple closure of the perforation and definitive surgery (VT + Dr).
Introduction of H2-blockers and proton pump inhibitors (PPIs) in
clinical practice and more precise knowledge about peptic ulcer
physiopathology that the studies of Helicobacter pylori brought us
during the 1990s provides patients with a high probability of cure
and a low rate of recurrence for the middle term, as shown by a well
conducted trial. These facts made medical treatment of PU disease
preferable to elective surgical treatment, whose dominant role has
remained unchanged when ulcer disease complications are in ques-
tion [1, 2]. This fact applies to treatment of the perforated PU,
whose incidence has remained stable or has slightly declined during
the second half of the twentieth century [3]. Today, however, some
claim that we are being faced with a higher rate of elderly people
affected by this complication.
The best surgical option for these patients is still in question.
Simple closure, regardless of whether protected with an epiploon
patch, continues to be the preferred option for many surgeons. It is
the easiest, quickest, safest operation, and it can be applied to all
situations by every surgeon; moreover, it can be complemented
later with an effective medical treatment that should include eradi-
cation of H. pylori. Other groups support the role of definitive sur-
gery, stating that this treatment, when indicated, does not increase
the morbidity or mortality due to the perforation. The purpose of
this study was to investigate the factors associated with the patients,
the perforations, and the operations performed. We then related
these factors to the postoperative complications and the mortality
of the patients.
Materials and Methods
Patients
A series of 210 consecutive patients with PU perforation associated
with peritonitis who required emergency surgery between January
1, 1990 and December 31, 2000 were included in this study. All
patients in whom a definitive histologic diagnosis revealed or con-
firmed the presence of a malignant lesion in the stomach were ex-
cluded. After the initial diagnosis and the usual reanimation mea-
sures (correcting the hydric, metabolic, and acid-base preexisting
imbalances, nasogastric intubation and aspiration, intravenous an-
tibiotics) the patients underwent surgical treatment.
At admission, complaints attributable to previous ulcerous dis-
ease; chronic ingestion of nonsteroidal antiinflammatory drugs
(NSAIDs), aspirin, corticosteroids, or immunosuppressants; alco-
hol ingestion and smoking habits; evolution of the acute episode
(hours); and the patient’s vital signs were recorded. Altogether, 124
patients had no associated pathology, and 86 were afflicted with
co-morbidities. Table 1 summarizes the clinical characteristics of
the patients.Correspondence to: Carlos Noguiera, M.D.
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Surgical Technique
The exact location of the perforation was confirmed by the surgeon
in the operating room. A total of 172 patients had pyloric (n = 88)
or bulbar (n = 84) perforations and were categorized as having a
duodenal ulcer (DU) perforation; 38 patients had a gastric ulcer
(GU) perforation.
In 88 patients (35 with a GU) closure of the perforation was per-
formed with or without an epiploon patch; 112 patients underwent
troncular vagotomy with a drainage operation (Weinberg or Finney
pyloroplasty or gastrojejunostomy) (VT + Dr); and 10 patients un-
derwent subtotal gastrectomy or vagotomy with antrectomy. Each
operation was the surgeon’s preference for the individual patient.
All GUs were biopsied during surgery. Treatment of the associ-
ated peritonitis consisted of mechanical cleansing of the peritoneal
cavity with saline in large quantities (> 3000 ml). Subhepatic drain-
age was optional and was rarely used; when it was used, it was
mainly during resection surgery.
Assessment Criteria
Treatment delay denotes the duration of time from the appearance
of the perforation to the start of the operation. The time of perfo-
ration (i.e., the start of acute symptoms) was determined by per-
sonal interview, from case notes, or from hospital records; the be-
ginning of the operation was obtained from the anesthesia record.
The criteria used refer to the postoperative complications (intra-
abdominal and general) and the surgical mortality (i.e., death oc-
curring within 4 weeks after surgery or during the hospitalization).
All information related to the preoperative evaluation, surgery per-
formed, and its complications were confirmed during personal in-
terviews conducted by one of three of the authors (C.N., A.S.S., or
J.N.S) . The data have been prospectively recorded since 1990 in a
database created with this purpose (Access for Windows) and
stored in a personal computer.
Statistical Analysis
The data analysis was performed with the SPSS9.0 program. The
frequencies of the used variables (sex, age, pulse and blood pres-
sure at admission, alcohol ingestion, smoking and drug habits, sig-
nificant co-morbidities, localization of the perforation, duration
and type of surgery performed) were compared by the 2 test with
Yates correction or by Fisher’s exact test. The association between
variables and the morbidity and mortality was estimated by the
odds ratio (OR) calculation and 95% confidence intervals (CI).
When univariate analysis of factors showed significant differ-
ences (p < 0.05) we calculated the adjusted OR by a multivariate
logistic regression model.
Results
A total of 88 patients (33 with a perforated GU) underwent simple
closure (covered with a patch of epiploon in 53). Another 122 un-
derwent definitive surgical treatment, which included 10 resection
procedures and 112 troncular vagotomies plus drainage opera-
tions.
Morbidity affected 37 (42.5%) of the patients in the simple clo-
sure group and 31 (25.4%) of those in whom definitive surgery was
performed. Some patients experienced more than one complica-
tion.
Altogether, 21 patients (10%) died as a consequence of the op-
eration: 15 (17.2%) after simple closure and 6 (4.9%) after defini-
tive surgery (3 after VT + Dr and 3 after resection surgery). Tables
2 and 3 show the causes of morbidity and mortality in our patients.
As shown in Table 4, the variables with statistical significance
that led to morbidity were age, pulse and blood pressure at admis-
sion, associated illnesses, perforation evolution, and type of surgery
performed. The logistic regression analysis (Table 5) adjusted each
of the variables to the others with significant OR found that only a
perforation evolution longer than 24 hours, associated illnesses,
and resection surgery were significant risks (Table 6). The variables
Table 3. Causes of mortality.
Cause of death No. of patients %
Sepsis 10 4.8
Respiratory failure 4 2.0
Myocardial infarction 2 1.0
Heart failure 1 0.5
Apoplexy 1 0.5
Unknown 3 1.5
Total 21 10.0
Table 1. Patients’ clinical features.
No. of patients 210 %
Age (years), mean ± SD 53.1 ± 20.6
Male 47.7 ± 17.3
Female 66.3 ± 22.0
Sex
Male 150 71.5
Female 60 28.5
Dyspepsia > 3 months 122 58.0
NSAIDs and steroid therapy 33 15.7
Delayed presentation (> 24 hours) 62 29.5
Shock on admission 25 11.9
Location
Pyloroduodenal 172 82.0
Gastric 38 18.0
Medical illness 86 40.9
Cardiovascular 34
Respiratory 20
Renal 11
Multiple arthroses 9
Diabetes mellitus 8
Hepatic cirrhosis 6
Rheumatoid arthritis 3
NSAIDS: nonsteroidal antiinflammatory drugs.
Table 2. Postoperative complications.
Complication No. %
Respiratory infection 24 11.4
Wound infection 12 5.7
Wound dehiscence 11 5.2
Suture leakage 7 3.3
Abdominal abscess 7 3.3
Peritonitis 7 3.3
Sepsis 6 2.8
Cardiovascular 6 2.8
Renal failure 3 1.4
Hepatic failure 2 0.95
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with statistical significance that led to mortality are the same as
those that led to morbidity (Table 7). They were blood pressure <
100 mmHg at admission, associated illnesses, and resection surgery
(Tables 8, 9).
Discussion
As in other centers, we have verified over the last few years a
marked decrease in the number of patients with uncomplicated PU
subjected to elective surgery. This has come about since the intro-
duction of H2-blockers and PPIs to clinical practice, complemented
by the eradication of H. pylori. This decline, however, was not as-
sociated with a decrease in the number of patients admitted with
PU perforation, similar to reports from other centers [1, 2, 4].
A total of 62 patients presented to our surgical department with
a perforated ulcer that had been present more than 24 hours. In
fact, 26 of the patients had had their perforated ulcers more than 48
hours). They are taken into account in Table 1 as delayed presen-
tations. Explanations for such delays are that, first, the patients find
it difficult to see their family doctors because they live in extremely
rural, backwoods areas. Second, our hospital receives patients re-
ferred by smaller hospitals, some of them located 100 km away,
which delays the patient’s presentation at our institution. A third
explanation is the advanced age of these patients. The average age
of patients who have had perforations of > 24 to < 47 hours of
evolution is 58.38 ± 22.77 years, the age of those with perforations
of > 48 hours’ evolution is 69.96 ± 17.51 years.
It has been noted in the literature that there is an increasing
number of elderly persons affected by this problem [4, 5], although
we did not see a significant number of elderly patients in our series.
In contrast to other reports that have indicated an increasing num-
ber of female patients affected by the disease over the past few
years [6, 7], we had a male/female ratio of 2.5:1.0.
What we did observe was a clear difference in the mean age rela-
tive to the appearance of this PU complication between men (47.7
± 17.3 years) and women (66.3 ± 22.0 years), for which we have no
convincing explanation.
Only 33 (15.7%) of our patients were taking NSAIDs at the time
of the perforation. There were clinical data suggesting the exis-
tence of previous PU disease in 122 patients, which may explain the
high rate of patients submitted to definitive surgery.
Table 4. Relation between morbidity and other variables.a
Variable
Patients
2 pNumber %
Sex
Male
Female
150
60
31.8
36.1
0.36 0.55
Age (years)
 50
50-69
 70
105
45
60
14.6
45.5
57.6
34.82 < 0.001
BP at admission (mmHg)
 100
< 100
163
25
30.1
52.0
4.72 0.03
Pulse at admission (beats/minute)
< 100
 100
129
36
30.2
50.0
4.86 0.03
Alcohol consumption
No
Yes
36
83
38.29
32.5
0.45 0.50
Smoking habit
No
Yes
41
84
31.7
27.4
0.25 0.62
NSAID use
No
Yes
46
35
26.1
40.0
1.76 0.18
Comorbidities
No
Yes
126
86
16.7
57.0
37.55 < 0.001
Evolution of perforation (hours)
 24
> 24
139
62
20.9
59.7
29.3 < 0.001
Operation
TV + Dr
Suture
Resection
112
88
10
20.5
43.2
80.0
22.03 < 0.001
Ulcer type
Gastric
Duodenal
38
172
42.1 1.67 0.20
TV + Dr, troncular vagotomy plus drainage operation; BP: blood pres-
sure.
aNumber of operations observed and percent complications.
Table 5. Univariate logistic regression: odds ratio and confidence
intervals at 95% (dependent variable: morbidity).
Variable OR 95% CI
Age (years)
< 50
50–69
 70
1.00
4.89
7.97
2.18–10.96
3.76–16.92
BP at admission (mmHg)
 100
< 100
1.00
2.52
1.07–5.91
Pulse at admission (beats/minute)
< 100
 100
1.00
2.31
1.09–4.91
Comorbidities
No
Yes
1.00
6.62
3.51–12.48
Evolution of perforation (hours)
 24
> 24
1.00
5.61
2.92–10.77
Operation
TV + Dr
Suture
Resection
1.00
2.94
15.48
1.58–5.48
3.08–77.89
Table 6. Multivariate logistic regression: adjusted odds ratio and CI at
95% (dependent variable: morbidity).
Variable OR 95% CI
Age (years)
 50
50–69
 70
1.00
2.76
2.62
0.99–7.70
0.97–7.12
BP at admission (mmHg)
 100
< 100
1.00
1.55
0.51–.4.71
Comorbidity
No
Yes
1.00
4.30
1.87–9.87
Evolution of perforation (hours)
 24
> 24
1.00
4.21
1.83–9.70
Operation
TV + Dr
Suture
Resection
1.00
0.98
21.95
0.41–2.31
3.43–140.59
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For decades the literature has reported conflicting data concern-
ing the impact of the evolution of the perforation (in hours) in
terms of surgical mortality. In series with large numbers of patients
[8, 9] it became clear that as the therapeutic delay increased so did
the mortality rate. Recent studies have expressed some doubt
about this supposition [10, 11]. Our analysis indicated that the criti-
cal point at which the therapeutic delay becomes significant is 24
hours after the perforation occurs.
The data we obtained shows that the risk of mortality and mor-
bidity is statistically significant (p < 0.001) when the patient is sub-
mitted to surgery with a perforation that is more than 24 hours old,
although this theory is not supported by the multivariate analysis
regarding mortality.
Another factor frequently noted in the literature regarding sur-
gical mortality is the coexistence of significant co-morbidities. This
factor was also found to be important in our series. The risk of
morbidity was six times higher and the risk of mortality twelve times
higher when we compared patients with or without associated co-
morbidities.
The factors mentioned above are in agreement with the analysis
reported by Boey et al. [12]. They claimed that postoperative mor-
tality is influenced by the presence of shock at admission or by an
interval between the perforation and treatment of more than 24
hours.
Our analysis confirmed that the presence of shock at admission
(BP maximum < 100 mmHg) was a determining factor in the pa-
tient’s final prognosis.
Surgical treatment for a perforated PU is, in our opinion, the
correct therapeutic option depending on the patient’s clinical con-
dition. A conservative approach (Taylor’s method) should be used
only in exceptional situations. Even during laparotomy it is possible
to mistake a perforated PU for a perforated tumor.
During the same period we observed 10 gastric cancer perfora-
tions. Closing the perforation was the only possible procedure for
six patients with unresectable disease. Two underwent a type R2
resection for advanced disease, and two were operated on with a
diagnosis of “benign disease.” All of these patients were excluded
from the study.
Table 7. Relation between mortality and other variables.
Variable
Patients
2 pNo. % Dead
Sex
Male
Female
150
60
7.3
19.7
5.67 0.02
Age (years)
 50
50-69
 70
105
45
60
1.0
11.4
28.8
29.32 < 0.001
BP at admission (mmHg)
 100
< 100
163
25
5.5
32.0
15.40 < 0.001
Pulse at admission (beats/minute)
< 100
 100
129
36
6.2
19.4
4.48 0.03
Alcohol consumption
No
Yes
36
83
8.3
3.6
0.43 0.51
Smoking habit
No
Yes
41
84
7.9
1.2
1.71 0.19
NSAID use
No
Yes
46
35
4.3
5.7
0.06 0.81
Comorbidity
No
Yes
124
86
2.4
23.3
20.92 < 0.001
Evolution of perforation (hours)
 24
> 24
139
62
3.6
24.2
18.07 < 0.001
Operation
TV + Dr
Suture
Resection
112
88
10
2.7
18.2
30.0
16.90 < 0.001
Ulcer type
Gastric
Duodenal
38
172
13.2
10.6
0.08 0.78
Table 8. Univariate logistic regression: odds ratio and CI at 95%
(dependent variable: mortality).
Variable OR 95% CI
Sex
Male
Female
1.00
3.12
1.29–7.52
Age (years)
 50
50-69
 70
1.00
13.07
41.27
1.48–115.45
5.32–320.06
BP at admission (mmHg)
 100
< 100
1.00
8.05
2.75–23.62
Pulse at admission (beats/minute)
< 100
 100
1.00
3.65 1.22–10.88
Comorbidity
No
Yes
1.00
12.42
3.56–43.33
Evolution of perforation (hours)
 24
> 24
1.00
8.55
2.95–24.82
Operation
TV + Dr
Suture
Resection
1.00
8.07
15.57
2.27–28.70
2.64–91.70
Table 9. Multivariate logistic regression: adjusted odds ratio and CI at
95% (dependent variable: mortality).
Variable OR 95% CI
Sex
Male
Female
1.00
0.37
0.08–1.72
Age (years)
 50
50–69
 70
1.00
2.35
6.59
0.16–33.73
0.55–78.84
BP at admission (mmHg)
 100
< 100
1.00
7.26
1.53–34.52
Comorbidity
No
Yes
1.00
18.06
1.67–195.58
Evolution of perforation (hours)
 24
> 24
1.00
3.18
0.74–13.59
Operation
TV + Dr
Suture
Resection
1.00
2.31
15.79
0.33–15.91
1.10–227.12
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An issue that remains under discussion is the appropriate surgi-
cal option (simple closure or definitive surgery) in view of the fact
that medical treatment today is so effective. In our patients a study
of the impact of the surgical procedure on their mortality revealed
that their survival was clearly affected by resection surgery. The
risks of simple closure of the perforation versus VT + Dr were the
same. This finding agrees with our recommendations, primarily in
situations where there are no risk factors and we are operating on
an “old” perforated PU, where definitive treatment of the disease
does not increase the possibility of morbidity and mortality. We do
not advise the use of resection surgery for a GU perforation, with or
without troncular vagotomy, as it is associated with a high risk of
mortality. The mortality in our series, which seems to have oc-
curred particularly in patients in whom closure of the perforation
was performed (15/88 patients), was 10%. Lower [13, 14] and
higher [15, 16] values have been reported in the English-language
literature, probably reflecting the different characteristics of the
populations treated in other hospitals. The high mortality rate for
the simple closure group is probably due to the choices made for
these patients when they are exposed to surgery. For instance, sur-
geons tend to shorten the operating time for patients at high risk.
This group includes elderly patients, usually with cardiovascular
disease, in whom the diagnosis is often late and peritonitis is of
accentuated gravity. Here the cause of death is usually persistent
sepsis or pulmonary failure, expressed as multiorgan failure.
Some have stated that GU perforation is associated with higher
mortality [17] than DU perforation. This was not observed in our
series, where we found no statistical difference (p = 0.78) between
the mortality rates for GU (13.2%) and DU (10.6%).
The improved prognosis for perforated PUs is associated with
effective prophylaxis of NSAIDs ulcers, whose incidence has been
rising worldwide with the increased consumption of these drugs
and the earlier diagnosis, especially in elderly people. On the other
hand, if data from other centers can be applied to our hospital, in
the future we may be operating on older patients more often than
we are today, making this task a difficult one [18] .
We believe that minimally invasive surgery can help decrease the
mortality associated with perforated PUs, but it is not yet clear if
this assumption will have an impact on mortality in the near future.
Re´sume´. Se nos jours, il est bien indique´ dans la litte´rature que le
traitement de choix me´dical de la maladie ulce´reuse est base´ sur
l’association d’inhibiteurs de la pompe a` protons (IPP) et des antibiotiques
pour l’e´radication d’Helicobacter pylori. Ce traitement a un taux e´leve´ de
succe`s imme´diats et un taux de re´cidive relativment bas a` 12 mois, bien
qu’ill ne soit pas efficace chez tous les patients. La perforation d’ulce`re
(PU) est une complication se´rieuse qui peut se voir pendant la maladie
ulce´reuse et qui, meˆme aujourd’hui, est associe´e a` une morbidite´ et
mortalite´ e´leve´es. Le traitement chirurgical, avec ses variations, constitue
le traitement ide´al de cette complication, et alors, on a le choix entre le
traitement simple de la perforation (suture) ou le traitement de´finitif de la
maladie ulce´reuse. Dans cette se´rie de 210 patients conse´cutifs (150
hommes et 60 femmes) ope´re´s dans le de´partement de chirurgie de notre
Hoˆpital pour PU entre 01/01/1990 et 31/12/2000, nous avons cherche´ a`
identifier les facteurs de risque (en rapport avec le patient, la complication
qu’est la perforation, et le type de chirurgie) de´terminants pour la
morbidite` et la mortalite´. La me´diane d’aˆge des patients a e´te´ de 53 ± 20.6
ans (hommes: 47.7 ± 17.3; femmes: 66.3 ± 22.0), 86 patients avaient une
co-morbidite´, 62 ont e´te´ admis plus de 24 heures apre´s la perforation et 25
en e´tat de choc. Nous avons re´alise´ une re´section chez 10 patients, une
suture de la perforation, avec ou sans e´piploplastie, chez 88, et une
vagotomie tronculaire + proce´de´ de drainage (V.T. + Dr.) chez 112
patients. Vingt et un patients sont de´ce´de´s (10%). Les facteurs de risque de
morbidite´ identifie´s par notre e´tude e´taient une perforation de plus de 24
heures, la co-existence de tares et la re´section chirurgicale; ceux de la
mortalite´ e´taient la pre´sence de choc a` l’admission, la co-existence de tares
et la re´section chirurgicale. En ce qui concernait la morbidite´ ou la
mortalite´, on n’a pas trouve´ de diffe´rence significative entre la suture
simple et la chirurgie de´finitive.
Resumen. En la actualidad, el tratamiento medico esta´ndar de la u´lcera
pe´ptica conlleva la administracio´n de inhibidores de la bomba de protones
(PPI) asociada a antibio´ticos con objeto de erradicar al Helicobacter pylori.
Este tratamiento proporciona un alto porcentaje de curaciones inmediatas
con escasas recidivas a los 12 meses; sin embargo no es eficaz en todos los
pacientes. La perforacio´n de la u´lcera pe´ptica (P.U.) es, incluso en la
actualidad, una grave complicacio´n pues cursa con elevadas tasas de
morbi-mortalidad. La cirugı´a con sus dintintas te´cnicas constituye el
tratamiento ideal para esta complicacio´n; puede limitarse a tratar
exclusivamente la perforacio´n o bien abordar el tratamiento definitivo de
la enfermedad ulcerosa. Con objecto de determinar, en nuestro Hospital,
las caracterı´sticas del paciente, la incidencia de la perforacio´n y la
influencia del tipo de cirugı´a realizada sobre la morbi-mortalidad, hemos
estudiado una serie de 210 pacientes (150 hombres y 60 mujeres)
ingresados en nuestro departamento de cirugı´a entre 01/01/1990 y 31/12/
2000 por perforacio´n de P.U. La edad media fue de 53 ± 20.6 an˜os (en
hombres: 47.7 ± 17.3; en mujeres: 66.3 ± 22). 86 pacientes tenı´an sensacio´n
de enfermedad grave; 62 ingresaron con una perforacio´n de ma´s de 24
horas de evolucio´n; 25 lo hicieron en estado de shock. En 10 pacientes se
efectuo´ una reseccio´n ga´strica, 88 fueron tratados mediante sutura de la
perforacio´n con o sin epiploplastia; en 112 se realizo´ una vagotomı´a
troncular y operacio´n de descarga (VT + Dr.) Murieron 21 pacientes
(10%). El estudio estadı´stico revelo´ que los factores ma´s importantes
determinantes de morbilidad fueron: perforacio´n de ma´s de 24 horas,
coexistencia con sensacio´n de enfermedad grave y la cirugı´a resectiva. Por
lo que a la mortalidad se refiere, los factores ma´s importantes fueron:
estado de shock al ingreso, sensacio´n de enfermedad grave y tratamiento
resectivo. No se registro´ diferencia alguna, por lo que a la morbi-
mortalidad se refiere, entre la simple sutura de la perforacio´n y el
tratamiento quiru´rgico definitivo de la enfermedad (V.T. + Dr.).
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